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Introduction
Alzheimer’s Disease International (ADI) published 
global prevalence data on dementia in the World 
Alzheimer Report 2009 1 based on a systematic 
review of 154 studies conducted worldwide, and 
United Nations population projections through to 
the year 2050. We estimated 36 million people with 
dementia in 2010, nearly doubling every 20 years to 
66 million by 2030 and to 115 million by 2050. 
Key findings included
• 58% of those affected lived in low and middle 
income countries, underlining the high impact of 
the condition in those regions, where awareness 
is low, health and social care are poorly 
developed and social protection is limited.
• Population ageing is the main driver of projected 
increases.
• We assumed that age-specific prevalence 
would remain constant. This assumption is 
challenged by recent evidence suggesting a 
modest recent decline in dementia prevalence 
in some higher income countries (HIC), but an 
increase in prevalence in China, likely linked to 
recent changes in population health, particularly 
exposure to cardiovascular risk factors.
• Since population ageing is occurring at an 
unprecedentedly fast rate in middle income 
countries, the bulk of the increase in numbers 
through to 2050 will occur in those regions. By 
2050 71% of those with dementia would be living 
in what are currently lower and middle-income 
countries (LMIC).
The Global Impact of Dementia 2013–2050
Although high income countries, including the G8, have borne the brunt of the dementia 
epidemic, this is a global phenomenon. Most people with dementia live in low and 
middle income countries, and most of the dramatic increases in numbers affected, 
through to 2050, will occur in those regions. In a spirit of international cooperation and 
solidarity we urge the G8 governments to sponsor intergovernmental action to make 
dementia a global priority. Crucially, this must include opening up access to diagnosis 
and current evidence-based treatment and care. All countries worldwide are failing in 
this basic objective. Action to address this problem should be balanced, as a priority, 
with research to improve treatment options and quality of care.
Since 2009, the global evidence base has 
expanded, most particularly with a new 
systematic review of the prevalence of 
dementia in China 3 comprising 75 studies, 
most published in Chinese language journals, 
and with seven studies from five sub-
Saharan African countries, where previously 
only one study from Nigeria had been 
available. 
The G8 Dementia Summit on 11 December 
2013 provides a timely opportunity to 
reassess and update evidence on the scale 
and the distribution of the global dementia 
epidemic, in particular its impact on more 
developed (G8, G20, OECD and ‘high 
income’ countries) and less developed ‘low 
and middle income’ countries. 
For the current update, we carried out a 
limited review, focusing on the new evidence 
emerging from China and the sub-Saharan 
African regions, and applied the new 
prevalence proportions to the latest (2012) 
UN population projections 2. Details of the 
methodology are provided in Annex 1. 
The work on this report has been a joint 
effort of the Global Observatory for Ageing 
and Dementia Care (Prof Martin Prince, 
Dr Maëlenn Guerchet and Dr Matthew Prina), 
and the ADI office.
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Figure 1 Original (2009 World Alzheimer Report) and updated age-specific prevalence of dementia (%) by region, 
showing impact of new data from Asia East (China) and Sub-Saharan Africa
Results
The prevalences of dementia estimated from the 
recent more comprehensive review and meta-
analysis of China studies 3 and our own meta-
analysis of studies from sub-Saharan Africa were 
substantially higher than those used in the 2009 
World Alzheimer Report. Age-standardised to a 
standard West European population, prevalence 
for East Asia increased from 4.98% to 6.99% 
and in the sub-Saharan African regions from a 
range of 2.07% to 4.00%, to 4.76% (Figure 1). 
The net effect, as more data becomes available, 
is to further reduce the variation in prevalence 
between world regions. 
The number of people living with dementia 
worldwide in 2013 is estimated at 44.35 million, 
reaching 75.62 million in 2030 and 135.46 million 
in 2050 (Figure 2). The updated estimates are 
higher than our original estimates reported in the 
2009 World Alzheimer Report, by 15% in 2030, 
and by 17% in 2050. 
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Figure 2 Increase in numbers of people with dementia worldwide (2010-2050), comparing original and 
updated estimates
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The largest increases in projected numbers of 
people with dementia are those for the Asia East 
and Sub-Saharan African regions, accounted 
for by the higher age-specific prevalence of 
dementia estimated in our new reviews of survey 
data from those regions (Annex 2). Hence, in 
2050 we are now estimating 33.61 million people 
with dementia in Asia East (an increase of 49% 
from the previous estimate of 22.54 million) and 
5.05 million older people with dementia in SSA 
(an increase of 136% from the previous estimate 
of 2.14 million). However, the new estimates of 
numbers of people with dementia are higher for 
all GBD regions than those estimated in 2009. 
This is explained by the underestimation of 
current numbers of older people in the previous 
UN population estimates (affecting the 2013 
figures), and revision upwards of probability of 
survival into older age (affecting the 2030 and 
2050 projections). 
We now estimate that while 32% of people 
with dementia live in G8 countries and 38% 
in high income countries, 62% live in low and 
middle income countries (Table 1). By 2050, the 
proportion living in G8 countries will have shrunk 
to 21%, while the proportion living in what are 
currently low and middle income countries will 
have increased to 71%.
Region
People with dementia millions 
(% of world total)
Proportionate increase  
(%) 
2013 2030 2050 2013-2030 2013-2050
G8 14.02 (32%) 20.38 (27%) 28.91 (21%) 45 106
G20 33.93 (76%) 56.40 (75%) 96.61 (71%) 66 185
OECD 18.08 (41%) 27.98 (37%) 43.65 (32%) 55 142
High income 17.00 (38%) 25.86 (34%) 39.19 (29%) 52 131
Low and middle income 27.84 (62%) 49.76 (66%) 96.27 (71%) 79 246
World 44.35 75.62 135.46 71 205
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Table 1 Updated estimates of the number of people with dementia living in G8, G20, 
OECD, LMIC and HIC countries, and as a percentage of world total
Figure 3 Number of people with dementia in low and middle income countries  
compared to high income countries 
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diagnosis; case management across the 
course of the illness; support, education and 
training for carers; optimising physical health; 
acetylcholinesterase inhibitors; cognitive 
stimulation; and non-pharmacological 
interventions for behavioural disturbance. 
Currently less than half of those in high 
income countries and fewer than 10% of 
those in LMIC have received a dementia 
diagnosis. 
8	 There are lessons to be drawn from the 
HIV epidemic. First, new and dramatically 
effective treatments can only be scaled up 
when diagnostic and care systems are well 
established. Second, affordable access 
to new diagnostic technologies and drug 
therapies will need rapidly to be extended 
to low and middle income country markets, 
where most of those who might benefit live. 
Third, those countries that where involved 
in ‘global trials’ should also benefit from 
treatments being made available at subsidised 
cost with adequate standards of care in place. 
9	 ADI and the World Health Organization have, 
in their joint report Dementia: a public health 
priority 13, called upon all Governments to 
make dementia a public and health priority. As 
part of this process, all governments should 
initiate national debates regarding the future 
provision and financing of long-term care 
(see World Alzheimer Report 2013: Journey 
of Caring 15). However, most are woefully 
unprepared for the dementia epidemic with 
only 13 countries having funded and sought to 
implement a national dementia plan. Without 
a plan, the risk is that health and social care 
systems will not cope with the increase 
in numbers and operate in crisis mode, 
escalating costs even further. 
10	At the eve of the G8 Dementia Summit in 
London, UK, it is not just the G8 countries, 
but all nations that must commit to a 
sustained increase in dementia research and 
a comprehensive plan for collaborative action 
involving all relevant government sectors, 
industry and civil society. International 
cooperation will be essential. There is a 
need for a collaborative, global action plan 
for governments, industry and non-profit 
organisations like Alzheimer associations. 
Priorities include; breaking down barriers to 
effective research; promoting rapid translation 
and ensuring equitable access to promising 
technologies and treatments; technical 
support for policymaking, health and social 
care service and system development. 
1	 Dementia, including Alzheimer’s disease, 
is one of the biggest global public health 
challenges facing our generation. Newly 
available data suggests that the current 
burden and future impact of the dementia 
epidemic has been underestimated, 
particularly for the Asia East and Sub-Saharan 
African regions.
2	 This is a global epidemic – although cases 
are disproportionately concentrated in the 
world’s richest and most demographically 
aged countries, already the clear majority 
(62%) of people with dementia live in low and 
middle income countries where access to 
social protection, services, support and care 
are very limited.
3	 In the next few decades, the global burden 
of dementia will shift inexorably to poorer 
countries, particularly rapidly developing 
middle income countries that are members of 
the G20, but not the G8.
4	 The future scale of the dementia epidemic 
may be blunted through improvements in 
population health, but our best estimates 
suggest that only up to 10% of incidence 
may thus be avoided 13. Public health and 
disease control measures targeting smoking, 
underactivity, obesity, hypertension and 
diabetes should be prioritised. Education and 
other factors that enhance brain and cognitive 
development will also improve the brain health 
of those entering old age, and reduce the 
incidence of dementia in late life. 
5	 Standard & Poor’s has described global 
population ageing as the biggest threat to 
the sustainability of sovereign debt. Among 
the chronic diseases, dementia makes by far 
the largest single contribution to disability 
and needs for care among older people. The 
current (2010) global societal economic cost 
of dementia is US$ 604 billion, or 1% of global 
GDP 14. Costs will escalate proportionately 
with numbers affected, and with increased 
demand for formal care services, particularly 
in low and middle income countries 13.
6	 Research must be a global priority if we 
are to improve the quality and coverage of 
care, find treatments that alter the course of 
the disease, and identify more options for 
prevention. 
7	 Investment in the search for a cure must be 
balanced with initiatives to improve access 
to currently available evidence-based 
packages of care – these include timely 
Conclusions and implications
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Estimation	of	the	number	of	people	with	
dementia	
The new rates were applied to the new UN population 
estimates for each 5-years age band (60-64, to 100 and 
over) 2. When rates were not available for one age-band 
(i.e. over 90 in SSA and over 100 in China), the rate of 
the nearest age-band was applied. As gender-specific 
estimates were available neither for China nor SSA, 
we applied the age-specific estimates to the whole 
population and to each gender separately. In the East Asia 
region – composed of China, Hong Kong SAR, Macao 
SAR, Chinese Taipei and DPR Korea – the new rates were 
applied to mainland China, Hong Kong SAR and Macao 
SAR, whereas the East Asia rates from the 2009 Word 
Alzheimer Report were maintained for the DPR Korea and 
Chinese Taipei.
For Sub-Saharan Africa, the new rates were applied to 
the countries belonging to the following Global Burden 
Disease (GBD) regions: SSA West, SSA Central, SSA East 
and SSA Southern. Based on the GBD regions, Algeria 
belongs to the North Africa / Middle East, so we therefore 
applied the EMRO B rates that are used for some of its 
neighbours.
For all the other regions, we applied the rates found in 
the 2009 World Alzheimer Report to the new population 
estimates from the United Nations 2.
Annex 1: Methods
The	prevalence	of	dementia	in	China	and	
Sub-Saharan	Africa
The estimates for China were revised based on the recent 
meta-analysis published by Chan et al. 3. This meta-
analysis included reports for dementia or Alzheimer’s 
Disease in mainland China, published in Chinese and 
English between 1990 and 2010. The rates applied to the 
population estimates were the age-specific prevalence of 
dementia in 2010. A new systematic review of dementia 
in China has also been recently published 4, together with 
a new large multi-centre population-based prevalence 
study of dementia in China 5. These studies were not 
taken into account in our estimates, but will be included in 
any future updates. 
For Sub-Saharan Africa, we conducted a systematic 
review of the literature on the prevalence of dementia with 
Pubmed / Medline up to October 2013 using a similar 
methodology and inclusion criteria that we used for the 
2009 World Alzheimer Report 1 (see online appendix). 
We sought and included population-based studies of the 
prevalence of dementia among people aged 60 years 
and over for which the fieldwork started on or after 1st 
January 1980. Prevalence rates were extracted for seven 
studies covering five different countries 6-12. A random 
effect exponential (Poisson) model was used to assess 
the effects of age on the prevalence of dementia. We 
then applied the relevant mean ages to the coefficients 
estimated from the model, to estimate prevalence in five 
year age-bands from 65-69 years to 85 years and over, 
for both sexes combined.
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Annex 2
GBD Region
Original estimates (2009) Updated estimates Proportionate increases  (%) for new estimates
2010 2030 2050 2013 2030 2050 2013- 2030 2013- 2050
Asia/Pacific 15.94 33.04 60.92 21.87 39.79 71.84 82 228
Australasia 0.31 0.53 0.79 0.37 0.62 1.02 68 176
Asia Pacific High Income 2.83 5.36 7.03 3.26 5.50 7.58 69 133
Oceania 0.02 0.04 0.10 0.02 0.04 0.09 100 350
Asia Central 0.33 0.56 1.19 0.29 0.44 0.88 52 203
Asia East 5.49 11.93 22.54 10.46 18.83 33.61 80 221
Asia South 4.48 9.31 18.12 4.74 8.50 16.61 79 250
Asia Southeast 2.48 5.30 11.13 2.74 5.87 12.05 114 340
Europe 9.95 13.95 18.65 10.93 14.8 20.75 35 90
Europe Central 1.10 1.57 2.10 1.23 1.69 2.29 37 86
Europe Eastern 1.87 2.36 3.10 1.86 2.03 2.44 9 31
Europe Western 6.98 10.03 13.44 7.84 11.08 16.02 41 104
The Americas 7.82 14.78 27.08 8.77 15.8 30.51 80 248
North America High Income 4.38 7.13 11.01 4.58 7.28 11.74 59 156
Caribbean 0.33 0.62 1.04 0.38 0.63 1.14 66 200
Latin America Andean 0.25 0.59 1.29 0.31 0.64 1.46 106 371
Latin America Central 1.19 2.79 6.37 1.38 2.95 7.07 114 412
Latin America Southern 0.61 1.08 1.83 0.71 1.17 2.13 65 200
Latin America Tropical 1.05 2.58 5.54 1.42 3.13 6.97 120 391
Africa 1.86 3.92 8.74 2.78 5.24 12.35 88 344
North Africa / Middle East 1.15 2.59 6.19 1.47 2.91 7.29 98 396
Sub-Saharan Africa Central 0.07 0.12 0.24 0.13 0.23 0.48 77 269
Sub-Saharan Africa East 0.36 0.69 1.38 0.55 1.06 2.45 93 345
Sub-Saharan Africa Southern 0.10 0.17 0.20 0.19 0.29 0.49 53 158
Sub-Saharan Africa West 0.18 0.35 0.72 0.44 0.76 1.63 73 270
World 35.56 65.69 115.38 44.35 75.62 135.46 71 205
Table 1 Numbers of people with dementia according to GBD regions (in millions, by year)
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About	Alzheimer’s	Disease	International	
Alzheimer’s Disease International (ADI) is the international federation of Alzheimer 
associations throughout the world. Each of our 79 members is a non-profit 
Alzheimer association supporting people with dementia and their families.
ADI was founded in 1984 and registered as a non-profit organization in the USA.  
Based in London, ADI is in official relations with the WHO since 1996 and has 
consultative status with the UN since 2012.
ADI’s vision is an improved quality of life for people with dementia and their 
families throughout the world. ADI aims to make dementia a global health priority, 
to build and strengthen Alzheimer associations, and to raise awareness about 
dementia worldwide. Stronger Alzheimer associations are better able to meet the 
needs of people with dementia and their carers, and to be the global voice on 
dementia.
Global	Observatory	for	Ageing	and	Dementia	Care	
The Global Observatory for Ageing and Dementia Care, hosted at the Health 
Service and Population Research Department, King’s College London, was 
founded in 2013. Supported by Alzheimer’s Disease International and King’s 
College London, the Observatory aims to synthesise global evidence for 
policymakers and the public through high impact evidence-based reports for 
Alzheimer’s Disease International (World Alzheimer Reports 2009, 2010, 2011 and 
2013), the World Health Organization (Dementia; a public health priority) and other 
relevant intergovernmental organisations. A particular focus is to identify and 
promote effective innovations in health and social care policy and practice.
